,Chapter 01: The Nursing Process and Drug Therapy......................................................................................... 7
I;, I;, I;, I;, I;, I;, I;,
Chapter 02: Pharmacologic Principles ............................................................................................................. 14
I;, I;, I;,
Chapter 03: Lifespan Considerations ............................................................................................................... 24
I;, I;, I;,
Chapter 04: Cultural, Legal, and Ethical Considerations................................................................................... 35
I;, I;, I;, I;, I;, I;,
Chapter 05: Medication Errors: Preventing and Responding .......................................................................... 45
I;, I;, I;, I;, I;, I;,
Chapter 06: Patient Education and Drug Therapy ........................................................................................... 50
I;, I;, I;, I;, I;, I;,
Chapter 07: Over-the-Counter Drugs and Herbal and DietarySupplements ................................................ 58
I;, I;, I;, I;, I;, I;, I;, I;,
Chapter 08: Gene Therapy and Pharmacogenomics ....................................................................................... 64
I;, I;, I;, I;, I;,
Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 68
I;, I;, I;, I;, I;, I;,
Chapter 10: Analgesic Drugs ........................................................................................................................... 85
I;, I;, I;,
Chapter 11: General and Local Anesthetics .................................................................................................... 97
I;, I;, I;, I;, I;,
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................... 105
I;, I;, I;, I;, I;, I;, I;, I;,
Chapter 13: Central Nervous System Stimulants and Related Drugs ............................................................. 115
I;, I;, I;, I;, I;, I;, I;, I;,
Chapter 14: Antiepileptic Drugs .................................................................................................................... 121
I;, I;, I;,
Chapter 15: Antiparkinson Drugs .................................................................................................................. 132
I;, I;, I;,
Chapter 16: Psychotherapeutic Drugs ........................................................................................................... 142
I;, I;, I;,
Chapter 17: Substance Use Disorder............................................................................................................. 156
I;, I;, I;, I;,
Chapter 18: Adrenergic Drugs....................................................................................................................... 162
I;, I;, I;,
Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................... 10
I;, I;, I;,
Chapter 20: Cholinergic Drugs....................................................................................................................... 116
I;, I;, I;,
Chapter 21: Cholinergic-Blocking Drugs .......................................................................................................... 11
I;, I;, I;,
Chapter 22: Antihypertensive Drugs ............................................................................................................. 126
I;, I;, I;,
Chapter 23: Antianginal Drugs ........................................................................................................................ 11
I;, I;, I;,
Chapter 24: Heart Failure Drugs.................................................................................................................... 129
I;, I;, I;, I;,
Chapter 25: Antidysrhythmic Drugs .............................................................................................................. 142
I;, I;, I;,
Chapter 26: Coagulation Modifier Drugs ....................................................................................................... 154
I;, I;, I;, I;,
Chapter 27: Antilipemic Drugs ...................................................................................................................... 166
I;, I;, I;,
Chapter 28: Diuretic Drugs ........................................................................................................................... 175
I;, I;, I;,
Chapter 29: Fluids and Electrolytes ............................................................................................................... 187
I;, I;, I;, I;,
Chapter 30: Pituitary Drugs ........................................................................................................................... 197
I;, I;, I;,
Chapter 31: Thyroid and Antithyroid Drugs .................................................................................................. 202
I;, I;, I;, I;, I;,
Chapter 32: Antidiabetic Drugs ..................................................................................................................... 210
I;, I;, I;,
Chapter 33: Adrenal Drugs ........................................................................................................................... 229
I;, I;, I;,
,Chapter 34: Women’s Health Drugs ............................................................................................................. 236
I;, I;, I;, I;,
Chapter 35: Men’s Health Drugs ................................................................................................................... 249
I;, I;, I;, I;,
Chapter 36: Antihistamines, Decongestants, Antitussives, andExpectorants ............................................ 259
I;, I;, I;, I;, I;, I;,
Chapter 37: Respiratory Drugs ...................................................................................................................... 270
I;, I;, I;,
Chapter 38: Antibiotics Part 1 ...................................................................................................................... 280
I;, I;, I;, I;,
Chapter 39: Antibiotics Part 2....................................................................................................................... 294
I;, I;, I;, I;,
Chapter 40: Antiviral Drugs ........................................................................................................................... 303
I;, I;, I;,
Chapter 41: Antitubercular Drugs ................................................................................................................. 313
I;, I;, I;,
Chapter 42: Antifungal Drugs ....................................................................................................................... 321
I;, I;, I;,
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ................................................................... 24
I;, I;, I;, I;, I;, I;,
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs ........................... 270
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugsand Miscellaneous Drugs ........... 283
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs............................................................ 292
I;, I;, I;, I;, I;, I;,
Chapter 48: Immunosuppressant Drugs........................................................................................................ 301
I;, I;, I;,
Chapter 49: Immunizing Drugs ..................................................................................................................... 311
I;, I;, I;,
Chapter 50: Acid-Controlling Drugs............................................................................................................... 320
I;, I;, I;,
Chapter 51: Bowel Disorder Drugs ................................................................................................................ 333
I;, I;, I;, I;,
Chapter 52: Antiemetic and Antinausea Drugs ............................................................................................. 348
I;, I;, I;, I;, I;,
Chapter 53: Vitamins and Minerals ............................................................................................................... 358
I;, I;, I;, I;,
Chapter 54: Anemia Drugs ............................................................................................................................ 369
I;, I;, I;,
Chapter 55: Nutritional Supplements ............................................................................................................ 382
I;, I;, I;,
Chapter 56: Dermatologic Drugs................................................................................................................... 389
I;, I;, I;,
Chapter 57: Ophthalmic Drugs ...................................................................................................................... 402
I;, I;, I;,
Chapter 58: Otic Drugs .................................................................................................................................. 410
I;, I;, I;,
, Chapter 01: The Nursing Process and Drug Therapy I;, I;, I;, I;, I;, I;, I;,
MULTIPLE CHOICE I;,
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
newlydiagnosed with type 2 diabetes. Which statement reflects the correct format for a
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
nursing diagnosis?
I;, I;,
a. Anxiety
b. Anxietyrelated to new drug therapy I;, I;, I;, I;, I;,
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
statementssuch as ―I‘m upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
d. Anxietyrelated to new drug therapy, as evidenced by statements such as ―I‘m
I;, I;, I;, I;, I;, I;, I;, I; , I;, I;, I;, I;,
upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;,
ANS: D I;,
Formulation of nursing diagnoses is usually a three-step process. ―Anxiety‖ is missing the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
―related to‖ and ―as evidenced by‖ portions of defining characteristics. ―Anxiety related to new
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
drug therapy‖ is missing the ―as evidenced by‖ portion of defining characteristics. The
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
statementbeginning ―Anxiety related to anxious feelings‖ is incorrect because the ―related to‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
section is simply a restatement of the problem ―anxiety,‖ not a separate factor related to the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
response.
I;,
DIF: COGNITIVE LEVEL: Understanding I;, I;,
(Comprehension)TOP: NURSING PROCESS: Nursing
I;, I;, I ; , I;, I;,
Diagnosis
I;,
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
I ; , I;, I;, I;, I;, I;, I;, I;, I;,
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
andgave the medication 2 hours after the scheduled dose was due. What type of problem does
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
this represent?
I;, I;,
a. ―Right time‖ I;,
b. ―Right dose‖ I;,
c. ―Right route‖ I;,
d. ―Right medication‖ I;,
ANS: A I;,
―Right time‖ is correct because the medication was given more than 30 minutes after the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
medication administration is scheduled. ―Route‖ is incorrect because the route is not affected.
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
―Medication‖ is incorrect because the medication ordered will not change. I;, I;, I;, I;, I;, I; , I;, I;, I;,
DIF: COGNITIVE LEVEL: Applying I;, I;,
(Application)TOP: NURSING PROCESS:
I;, I;, I ; , I;,
Implementation
I;,
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
I ; , I;, I;, I;, I;, I;, I;, I;, I;, I;,
3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,
I;, doseand documenting the patient‘s therapeutic response to the medication. Which phase of
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,